EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Impact of Polyvascular Disease on the Trajectory of Patients with New-onset Atrial Fibrillation: a linked-dataset UK study

Hiroyuki Yoshimura, Jun Jiang, Gregory Y H Lip, Floriaan Schmidt, Rui Providencia

European Heart Journal Open · 2026-11-11

DOI: 10.1093/ehjopen/oeag190 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Atrial fibrillation (AF) frequently coexists with atherosclerotic disease, but the impact of polyvascular involvement on clinical outcomes and risk stratification remains unclear. Methods Using linked UK electronic health records, we identified patients with newly diagnosed AF between 1998 and 2016. Patients were classified according to vascular disease extent (none, single-arterial, or polyvascular). Associations with mortality and cardiovascular events were assessed using Cox regression. We evaluated whether adding one point for polyvascular disease to the CHA2DS2VA score improved discrimination for stroke and systemic embolism. Results Among 198,995 patients, 10.3% had polyvascular disease and 33.9% had single-arterial involvement. Over a median follow-up of 5.9 years, increasing vascular burden was associated with greater comorbidity and higher rates of cardiovascular events. All-cause mortality increased progressively across patients with no vascular disease (42.7%), single-arterial disease (53.2%), and polyvascular disease (62.3%; log-rank P<0.001). Following multivariable adjustment, both single-arterial (hazard ratio [HR] 1.17, 95% confidence interval [CI] 1.16–1.19) and polyvascular disease (HR 1.43, 95% CI 1.40–1.46) independently predicted mortality. Polyvascular disease was also associated with increased risks of heart failure hospitalization, myocardial infarction, and ischemic stroke. Adding polyvascular disease to the CHA2DS2VA risk scheme did not result in an appreciable change in discriminative performance for ischemic stroke (c-index 0.67, 95%CI 0.66-0.67 for both CHA2DS2VA and CHA2DS2VA+polyvascular). Conclusions Vascular disease is common in newly diagnosed AF and is associated with progressively worse cardiovascular outcomes and survival. Incorporating polyvascular disease in the CHA2DS2VA score did not enhance its discriminative capacity.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →